StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $708.81MP/E –Yield –

Earnings

Achieve Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.11
-$0.28 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Achieve Life Sciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 23, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026after the close––-$0.11Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open––-$0.19Release
Q4 FY2025ended Dec 31, 2025Mar 24, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025before the open––-$0.28Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025before the open––-$0.37Release
Q1 FY2025ended Mar 31, 2025May 13, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 11, 2025before the open––-$0.36Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close––-$0.36Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024after the close––-$0.25Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close––-$0.26Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Achieve Life Sciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Achieve Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Achieve Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Update
  5. Results
  6. Results
  7. Results
  8. News
  9. News
  10. Results
  11. Results
  12. News
  13. Results
  14. Results
  15. Results

See a number that looks wrong?